Stryker, a Michigan-based company that manufactures surgical implants, confirmed it was experiencing a global network outage. Employee devices reportedly displayed the logo of a pro-Iran cybercrime cell.
The U.S. Department of Justice said the insurer upcoded patient diagnoses to boost risk-adjusted payments it received from the Centers for Medicare & Medicaid Services. The company did not admit to wrongdoing, despite agreeing to the payout.
BrainBot's development represents a significant step forward for image-guided interventional procedures, as fully robotic neurosurgical devices are not designed to be MRI-compatible.
Clestina Lamai, the surgical technician, claimed in a lawsuit that Iowa Methodist Medical Center removed her from surgery at the request of a racist patient. The case was settled as a jury was set to deliver its verdict, local media reports.
The U.S. Department of Justice said ExThera cooperated with the investigation into a failure to file adverse event notices with the Food and Drug Administration after two cancer patients who used its blood filtration systems in Antigua died shortly after returning home. The California-based company’s former chief regulatory officer has agreed to plead guilty and could serve prison time.
Tenaya Therapeutics and Alnylam Pharmaceuticals have agreed to collaborate on identifying potential new gene therapies for the treatment of cardiovascular disease. Tenaya will receive an upfront payment of $10 million, but stands to earn much more.
